Skip to content

Malmö Treatment Referral and Intervention Study

Malmö Treatment Referral and Intervention Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01457872
Acronym
MATRIS
Enrollment
79
Registered
2011-10-24
Start date
2011-10-31
Completion date
2013-04-30
Last updated
2014-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heroin Addiction, Substance Use Disorders

Keywords

Heroin addiction, Substance use disorders, Substitution treatment, Syringe exchange

Brief summary

This study aims to study and implement active referral of heroin users from a syringe exchange programme to evidence-based treatment for heroin addiction. Patients are randomized to either a strength-based case management intervention or a control group, while both groups receive referral to medical investigation for inclusion in substitution treatment for heroin addiction. The hypothesis is that syringe exchange can be used for referral to effective treatment, and that a strength-based intervention can increase the number of patients who are successfully referred and enter treatment.

Detailed description

Patients attending the syringe exchange programme of Malmö, Sweden, and who are using heroin as their primary drug of abuse and who live in the catchment area of Malmö Addiction Centre, will be addressed, and patients willing to participate will undergo a baseline interview and will be referred to medical examination for decision to start substitution treatment to treat heroin dependence. Half of patients will be randomized to a strength-based case management intervention, hypothesized to facilitate treatment entry, and half of patients will be randomized to a control condition involving only referral. The study will measure the number of patients who successfully accept referral and initiate substitution treatment for heroin dependence, comparing patients in intervention arm to patients in the control condition (RCT design). Also, as a secondary outcome measure, retention and treatment outcome (substance use and clinical characteristics) will be compared between the two groups. In addition, this study will enable a number of sub-analyses aiming to increase knowledge about heroin addicts' detailed substance use pattern and clinical characteristics. Patients will be followed with respect to retention, substance use and clinical picture for three years.

Interventions

BEHAVIORALStrength-based case management

Strength-based case management

BEHAVIORALControl condition - referral only

Referral only

Sponsors

Swedish Council for Working Life and Social Research
CollaboratorOTHER
Region Skane
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Registered at syringe exchange programme of Malmö * Primary drug heroin * Heroin dependence * Living in catchment area for substitution treatment of Addiction Centre Malmö

Exclusion criteria

* Inability to understand consent and information * Unstable psychiatric condition making treatment regulations impossible * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Treatment entry in substitution treatment at two time points - directly after referral and after up to 3 monthsAt medical examination after 10 days, and subsequently for up to 3 monthsPercentage of patients successfully referred for examination and start of substitution treatment. This is measured at two time points, at 10 days post-referral when the medical examination is carried out (the percentage of patients who successfully show up) and subsequently the patients will be followed up to three months post-referral with respect to actual initiation of medication.

Secondary

MeasureTime frameDescription
Retention and treatment outcome in substitution treatment3, 6, 12, 24, 26 monthsPercentage of patients remaining in treatment. Treatment outcome including decrease in substance use and improvement in clinical picture.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026